The development of estrogen and progestin radiopharmaceuticals for imaging breast cancer

Anticancer Research

Volumn 17, Issue 3 B, 1997, Pages 1573-1576

  Katzenellenbogen, John A ^a   Welch, Michael J ^b   Dehdashti, Farrokh ^b  

^a UNIVERSITY OF ILLINOIS AT URBANA CHAMPAIGN   (United States)

^b WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Breast cancer; Estrogen receptor; Fluorine 18; Positron emission tomography; Progestin receptor; Technetium 99m

Indexed keywords

16ALPHA FLUOROESTRADIOL; ESTROGEN DERIVATIVE; ESTROGEN RECEPTOR; FLUORINE 18; FLUORODEOXYGLUCOSE; PROGESTERONE DERIVATIVE; PROGESTERONE RECEPTOR; RADIOISOTOPE; TAMOXIFEN; TECHNETIUM 99M; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BREAST CANCER; BREAST TUMOR; CANCER HORMONE THERAPY; CONTROLLED STUDY; DIAGNOSTIC IMAGING; DRUG DISTRIBUTION; FEMALE; INTRAVENOUS DRUG ADMINISTRATION; NONHUMAN; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; RAT; TARGET ORGAN; TISSUE DISTRIBUTION;

ANIMALS; ANTINEOPLASTIC AGENTS, HORMONAL; BREAST NEOPLASMS; DEOXYGLUCOSE; ESTRADIOL; FEMALE; FLUORINE RADIOISOTOPES; FLUORODEOXYGLUCOSE F18; HUMANS; RATS; RECEPTORS, ESTROGEN; RECEPTORS, PROGESTERONE; TAMOXIFEN; TISSUE DISTRIBUTION; TOMOGRAPHY, EMISSION-COMPUTED;

EID: 0031005262     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (21)

1. Katzenellenbogen JA, Heiman DF, Carlson KE and Lloyd JE: In vivo and in vitro steroid receptor assays in the design of estrogen radiopharmaceuticals. In: Receptor-Binding Radiotracers, volume 1 (Eckelman WC, ed). Boca Raton, Florida, CRC Press, Inc., 1982, PP 93-126.
2. Kiesewetter DO, Katzenellenbogen JA, Kilbourn MR and Welch MJ: The synthesis of 16-fluoroestrogens by unusually facile fluoride ion displacement reactions: Prospects for the preparation of fluorine-18 labeled estrogens. J Org Chem 49: 4900-4905, 1984.
3. Pomper MG, VanBrocklin H, Thieme AM, Thomas RD, Kiesewetter DO, Carlson KE, Mathias CJ, Welch MJ and Katzenellenbogen JA: 11ß-Methoxy-, 11ß-ethyl- and 17α-ethynyl-substituted 16afluoroestradiols: Receptor-based imaging agents with enhanced uptake efficiency and selectivity. J Med Chem 33: 3143-3155, 1990.
4. 18F]Fluoro)estrogens: Systematic investigation of a new series of fluorine- 18-labeled estrogens as potential imaging agents for estrogen-receptor-positive breast tumors. J Med Chem 36: 1619-1629, 1993.
5. Kiesewetter DO, Kilbourn MR, Landvatter SW, Heiman DF, Katzenellenbogen JA and Welch MJ: Preparation of four fluorine-18-labeled estrogens and their selective uptakes in target tissues of immature rats. J Nucl Med 25: 1212-1221, 1984.
6. 18F]Fluoro-16ct-ethyl-19-norprogesterone: Synthesis and target tissue selective uptake of a progestin receptor based radiotracer for positron emission tomography. J Med Chem 31: 13601363, 1988.
7. 18 F]fluoro-16α-ethyl-19-norprogesterone as a positron-emitting radiopharmaceutical for the detection of progestin receptors in human breast carcinomas. J Nucl Med 32: 1532-1537, 1991.
8. 18 F]fluoro-16a-ethyl-19-norprogesterone) in humans: a clue for future investigations. Nucl Med Biol 21: 941-952, 1994.
9. Feliu AL and Rottenberg DA: Synthesis and evaluation of fluorine-18 21-fluoroprednisone as a potential ligand for neuro-PET studies. J Nucl Med 28: 998-1005, 1987.
10. Kochanny MJ, VanBrocklin HF, Kym PR, Carlson KE, O'Neil JP, Bonasera TA, Welch MJ and Katzenellenbogen JA: Fluorine-18-labeled progestin ketals: Synthesis and target tissue uptake selectivity of potential imaging agents for receptor-positive breast tumors. J Med Chem 36: 1120-1127, 1993.
11. Buckman BO, Bonasera TA, Kirschbaum KS, Welch MJ and Katzenellenbogen JA: Fluorine-18-labeled progestin 16α,17αdioxolanes: Development of high-affinity ligands for the progesterone receptor with high in vivo target site selectivity. J Med Chem 38: 328-337, 1995.
12. Mintun MA, Welch MJ, Siegel BA, Mathias CJ, Brodack JW, McGuire AH and Katzenellenbogen JA: Breast cancer: PET imaging of estrogen receptors. Radiology 169: 45-48, 1988.
13. Dehdashti F, Mortimer JE, Siegel BA, Griffith LK, Bonasera TJ, Fusselman MJ, Detert DD, Cutler PD, Katzenellenbogen JA and Welch MJ: Positron tomographic assessment of estrogen receptors in breast cancer: comparison with FDG-PET and in vitro receptor assays. J Nucl Med 36: 1766-1774, 1995.
14. McGuire AH, Dehdashti F, Siegel BA, Lyss AP, Brodack JW, Mathias CJ, Mintun MA, Katzenellenbogen JA and Welch MJ: Positron tomographic assessment of 16a-[18F]fluoro-17b-estradiol uptake in metastatic breast carcinoma. J Nucl Med 32: 1526-1531, 1991.
15. Flanagan FL, Dehdashti F, Mortimer JE, Siegel BA, Jonson S and Welch, MJ: PET assessment of response to tamoxifen therapy in patients with metastatic breast cancer. J Nucl Med 37(supplement): 99P, 1996.
16. Clarysse A: Hormone-induced tumor flare. Eur J Cancer Clin Oncol 27:545-547, 1985.
17. Top S, El Hafa H, Vessiéres A, Quivy J, Vaissermann J, Hughes DW, McGlinchey MJ, Mornon J-P, Thoreau E and Jaouen G: Rhenium carbonyl complexes of b-estradiol derivatives with high affinity for the estradiol receptor: An approach to selective organometallic radiopharmaceuticals. J Am Chem Soc 177: 8372-8380, 1995.
18. DiZio JP, Fiaschi R, Davison A, Jones AG and Katzenellenbogen JA: Progestin-rhenium complexes: Metal-labeled steroids with high receptor binding affinity, potential receptor-directed agents for diagnostic imaging or therapy. Bioconjugate Chem 2: 353-366, 1991.
19. DiZio JP, Andxerson CJ, Davison A, Ehrhardt GJ, Carlson KE, Welch MJ and Katzenellenbogen JA: Technetium- and rhenium-labeled progestins: Synthesis, receptor binding and in vivo distribution of an 11b-substituted progestin labeled with technetium-99 and rhenium186. J Nucl Med 33: 558-569, 1992.
20. O'Neil JP, Carlson KE, Anderson CJ, Welch MJ and Katzenellenbogen JA: Progestin radiopharmaceuticals labeled with technetium and rhenium: Synthesis, binding affinity, and in vivo distribution of a new progestin N2S2-metal conjugate. Bioconjugate Chem 5: 182-193, 1994.
21. Horn RK, Chi DY and Katzenellenbogen JA: Heterodimeric bis(amino thiol) complexes of oxorhenium(V) and oxotechnetium(V) that mimic the structure of steroid hormones. Synthesis and stereochemical issues. J Org Chem 61: 2624-2631, 1996